← Leaderboards
James N Petitte
North Carolina State University Raleigh
$377,258
Attributed
$1,124,374
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $409.2K · FY2011–13$500K$375K$250K$125K$0
'11
'12
'13
Funding mix
By agency
NIH$1,124,374 · 1
By mechanism
R33$1,124,374 · 1
Top collaborators
- David C. Muddiman5 shared
- Daniel L Comins3 shared
- Adam M Hawkridge3 shared
Most similar at North Carolina State University Raleigh
Same institution · by research overlap
- Yoshiaki Tsuji$3,621,240
- John Cavanagh$4,088,001
- Paul F Agris$1,797,882
- Daniel L Comins$1,432,364
- Jack Ray Edwards$115,601
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisAnimal ModelAnalytical ToolAge-MonthsBaseBiobankBiologicalAnimalsAnticancer ResearchBirdsBloodCa-125 AntigenChargeChemistryChickensCleaved CellCohortCollectionCommunitiesComparativeComplex MixturesDesignDetectionDiagnostic
Grant awards (5)
Development and Application of Novel Glycan-Specific Reagents to Facilitate Early$332,549
R33 · FY2013 · CA
Development and Application of Novel Glycan-Specific Reagents to Facilitate Early$52,110
R33 · FY2013 · CA
Development and Application of Novel Glycan-Specific Reagents to Facilitate Early$353,783
R33 · FY2012 · CA
Development and Application of Novel Glycan-Specific Reagents to Facilitate Early$55,436
R33 · FY2012 · CA
Development and Application of Novel Glycan-Specific Reagents to Facilitate Early$330,496
R33 · FY2011 · CA